Insider Transactions Reported by 26 Insiders of Oruka Therapeutics, Inc.

Symbol
ORKA on Nasdaq
Location
Menlo Park, CA

Insiders trading volume in the past year

Oruka Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fairmount Funds Management LLC Director, 10%+ Owner $54,318,009 17 Sep 2025
Venrock Healthcare Capital Partners III, L.P. 10%+ Owner $47,458,016 +$1,407,368 +3.1% 10 Feb 2025
Funicular Funds, LP Other*, 10%+ Owner $22,903,390 15 Dec 2022
Funicular Fund, LP Other* $6,451,130 23 May 2022
JANUS HENDERSON GROUP PLC 10%+ Owner $6,302,520 16 Aug 2024
Laura Sandler Chief Operating Officer $6,101,987 -$370,795 -5.7% 02 Jan 2026
Lawrence Otto Klein Chief Executive Officer, Director $2,537,240 22 Jan 2025
Cameron Turtle Director $253,722 02 Jun 2025
Christopher David Ozeroff S.V.P., General Counsel $127,425 14 Dec 2021
ROBERT E. CONWAY Director, Chairman of the Board $125,000 30 Jan 2024
Thomas A. Keuer Chief Operating Officer $101,825 08 Dec 2022
C. Jeffrey Dekker Chief Financial Officer $100,000 08 Dec 2022
Joana Goncalves Chief Medical Officer $47,936 -$214,293 -82% 19 Dec 2025
MICHAEL R. BRISTOW Pres. & Chief Executive Offic, Director $12,021 14 Dec 2021
DANIEL J. MITCHELL Director $1,528 30 Jan 2024
Linda Grais Director 30 Jan 2024
Raymond L. Woosley Director 30 Jan 2024
Jacob Ma-Weaver Other* 29 Aug 2024
Anders D. Hove Director 30 Jan 2024
James P. Flynn Director 30 Jan 2024
Arjun Agarwal SVP, Finance 22 Jan 2025
Christopher Martin Director 11 Dec 2025
KRISTINE BALL Director 02 Jun 2025
Samarth Kulkarni Director 02 Jun 2025
Carl Dambkowski Director 02 Jun 2025
Paul Quinlan General Counsel 22 Jan 2025

Recent Insider Transactions by Companies or Individuals for Oruka Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.